We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




An Intelligent Surgical Instrument Aids Surgery

By HospiMedica staff writers
Posted on 16 Oct 2007
A new surgical instrument for open and endoscopic surgery offers computer-assisted,power-actuated support for cutting, stapling, and tissue manipulation in a variety of procedures in open and minimally invasive surgery. More...


The i60 Intelligent Surgical Instrument is intended for use in gastrointestinal, gynecological, abdominal, and thoracic surgical procedures for resection, transection, creation of anastomoses, and open occlusion of the heart's left atrial appendage. The surgical instrument is controlled by drive motors, motor control circuits, and clinician-feedback technology that have been miniaturized and integrated into the handpiece. The hand held surgical device is operated with digital controls located in the handle, and does not require a power console or a flexible connection shaft to work. At the push of a button, the i60 places four rows of titanium staples in tissue while simultaneously cutting between them.

The i60 also offers articulation capabilities that enable it to mimic the articulation of the human wrist, enabling surgeons to access difficult to reach anatomy, and allowing for more flexible manipulation, enhanced dexterity and increased ease of use. The i60 Intelligent Surgical Instrument is a product of Power Medical Interventions (PMI, Langhorne, PA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"The i60 is the first of PMI's next generation of intelligent surgical instruments. PMI is pioneering this exciting new technology platform for use in both open and laparoscopic surgery,” said Michael Whitman, founder, president and CEO of PMI. "The i60 and its derivatives are also being developed for the emerging field of Natural Orifice Translumenal Endoscopic Surgery (NOTES).”


Related Links:
Power Medical Interventions

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.